Literature DB >> 15891761

Coronary artery vasospasm during dobutamine stress echocardiography.

Amar D Patel1, Stamatios Lerakis, Achilles Zacharoulis, Randolph P Martin.   

Abstract

Compared with the frequent occurrence of S-T segment depression, the development of S-T segment elevation during dobutamine stress echocardiography is a relatively rare finding, especially in the setting of nonobstructive coronary artery disease. We present two patients who developed chest discomfort with S-T segment elevation during dobutamine stress testing. Both patients had unremarkable baseline echocardiograms and no history suggestive of coronary vasospasm. Subsequent coronary angiography revealed nonobstructive disease. It is speculated that the likely presence of endothelial dysfunction coupled with mild coronary atherosclerosis caused an imbalance between the coronary vasodilatory and vasoconstrictive forces. The inhibition of the vasodilatory effects of beta-adrenergic receptor stimulation and flow-mediated dilation of dobutamine was overcome by the vasoconstrictive effects of dobutamine-stimulated alpha-1 receptor activation; thus, contributing to the development of coronary vasospasm. This condition is important to recognize and appreciate as the initial treatment for this condition favors the use of nitrates over beta-blockade.

Entities:  

Mesh:

Year:  2005        PMID: 15891761     DOI: 10.1016/j.echo.2005.02.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  2 in total

1.  Dobutamine-induced myocardial infarction with normal coronary arteries during stress SPECT myocardial perfusion imaging.

Authors:  Steven A Lubitz; W Lane Duvall; Michael C Kim; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2007-06-20       Impact factor: 5.952

2.  Dobutamine stress testing induced transient cardiomyopathy: A systematic review.

Authors:  Satish Chandraprakasam; Venkata M Alla; Aryan N Mooss; Claire B Hunter
Journal:  Int J Cardiol Heart Vessel       Date:  2014-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.